Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer.
Cancer. 2024 Mar 1;130(5):683-691. doi: 10.1002/cncr.35090. Epub 2023 Oct 31.
Cancer. 2024.
PMID: 37905752
Clinical Trial.
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS.
van Dorp J, et al. Among authors: daletzakis a.
Nat Med. 2024 Jan;30(1):304. doi: 10.1038/s41591-023-02500-7.
Nat Med. 2024.
PMID: 37460757
No abstract available.
Item in Clipboard
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS.
van Dorp J, et al. Among authors: daletzakis a.
Nat Med. 2023 Mar;29(3):588-592. doi: 10.1038/s41591-022-02199-y. Epub 2023 Feb 2.
Nat Med. 2023.
PMID: 36732628
Clinical Trial.
Item in Clipboard
Estimation and expected sample size in Simon's two-stage designs that stop as early as possible.
Daletzakis A, van den Bor R, Jonker MA, Roes KCB, van Tinteren H.
Daletzakis A, et al.
Pharm Stat. 2022 Sep;21(5):879-894. doi: 10.1002/pst.2200. Epub 2022 Feb 22.
Pharm Stat. 2022.
PMID: 35191174
Item in Clipboard
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
de Boo L, Cimino-Mathews A, Lubeck Y, Daletzakis A, Opdam M, Sanders J, Hooijberg E, van Rossum A, Loncova Z, Rieder D, Trajanoski Z, Vollebergh M, Sobral-Leite M, van de Vijver K, Broeks A, van der Wiel R, van Tinteren H, Linn S, Horlings HM, Kok M.
de Boo L, et al. Among authors: daletzakis a.
Eur J Cancer. 2020 Mar;127:240-250. doi: 10.1016/j.ejca.2019.12.003. Epub 2020 Jan 16.
Eur J Cancer. 2020.
PMID: 31956037
Clinical Trial.
Item in Clipboard
Cite
Cite